Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorYıldız, Erkan
dc.contributor.authorBalcı, Aydın
dc.contributor.authorSelendili, Okan
dc.contributor.authorKuzu, Selçuk
dc.date.accessioned2021-05-05T22:11:49Z
dc.date.available2021-05-05T22:11:49Z
dc.date.issued2021
dc.identifier.issn0145-5613
dc.identifier.urihttps://doi.org/10.1177/01455613211011285
dc.identifier.urihttps://hdl.handle.net/20.500.12933/159
dc.descriptionPubMed: 33881955en_US
dc.description2-s2.0-85104858962en_US
dc.description.abstractObjectives: Besides the common symptoms of the coronavirus disease 2019 (COVID-19) including fever, shortness of breath, and cough, a “sudden loss of smell” has recently been added as a diagnostic symptom. The relationship between paranasal sinus computed tomography (PNS CT) and sudden loss of smell in COVID-19 was examined. Materials and Methods: Two groups were selected for the study, the COVID-19 and the control groups. The control group consisted of 40 patients who applied to our clinic with headache and therefore underwent PNS CT. The other group consisted of 40 patients with COVID-19 who were diagnosed with sudden loss of smell with the Connecticut Chemosensory Clinical Research Center (CCCRC) olfactory test. Clinical and demographic characteristics, tomography results, and olfactory test scores of patients with COVID-19 loss of smell and control group patients were recorded. The relationship between CT changes in the olfactory cleft and the degree of loss of smell was evaluated. The “Opacification in the olfactory cleft” was accepted as a positive CT finding. Results: Comparison of patients with COVID-19 who had a loss of smell and the control group indicated that a significant difference was observed in terms of CT findings (P =.022). When we evaluated the paranasal CTs obtained from our patients with loss of smell, the CT of 13 patients showed pathological findings (P <.05). As the COVID-19 progressed (pneumonia and respiratory failure), the degree of loss of smell increased (P <.05). A statistically significant relationship was found between the CCCRC score and the presence of PNS CT findings (P =.0012). Conclusion: The PNS CT findings are significant in patients with COVID-19 with a loss of smell and were significantly associated with the degree of loss of smell. In patients with olfactory loss due to COVID-19, PNS CT can help in diagnosis. However, for this imaging to be diagnostic, a larger patient series is needed. © The Author(s) 2021.en_US
dc.language.isoengen_US
dc.publisherSAGE Publications Ltden_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOVID-19en_US
dc.subjectdiagnostic imagingen_US
dc.subjectolfactory lossen_US
dc.subjectparanasal sinus CTen_US
dc.subjectPVODen_US
dc.subjectSARS-CoV-2en_US
dc.titleOlfactory Cleft Opacification in COVID-19 Related Smell Loss: CT Findings and Correlation With Objective Testingen_US
dc.typearticleen_US
dc.departmentAFSÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kulak Burun ve Boğaz Hastalıkları Ana Bilim Dalı
dc.contributor.institutionauthorKuzu, Selçuk
dc.identifier.doi10.1177/01455613211011285
dc.relation.journalEar, Nose and Throat Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster